Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial

Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial

<p>Abstract</p> <p>Background</p> <p>Tuberous sclerosis (TS) is a rare autosomal dominant systemic disease with an estimated prevalence of 1/6000. Renal angiomyolipoma (AML) is a benign tumour with high morbidity frequently present in TS. The aim of the study was to tes...

Full description

Bibliographic Details
Main Authors: Cabrera-López Cristina, Martí Teresa, Catalá Violeta, Torres Ferran, Mateu Silvia, Ballarín Jose, Torra Roser
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Angiomyolipoma
mTOR
Rapamycin
Treatment
Tuberous sclerosis
Online Access:http://www.ojrd.com/content/7/1/87

Similar Items

Similar Items